Sep 22, 2023 · 1h 42m · allin
E146: Did the Fed break the VC model? Plus IPOs, M&A, revaluing unicorns & more
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In Episode 146 of the All-In Podcast, the co-hosts analyze the shifting venture capital landscape, examining recent IPOs, overvalued unicorns, and the Federal Reserve's 'higher for longer' interest rate policy. They also review the 2023 All-In Summit, debate political primary dynamics, and discuss groundbreaking research on inverse vaccines for autoimmune diseases.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. The hosts hold 99.6% of the talking time here. How this is scored →
speaking balance: gold is the hosts, purple is the guest (3 minute bins)
Sacks forcefully interjects to reject any optimistic framing around startup recaps, calling them completely predatory maneuvers that wipe out common shareholders.
Hardest push from the hosts ▶ 6:19 Sacks rejects Friedberg's framing on fiscal prioritiesSacks firmly pushes back on Friedberg's contention that fiscal deficits take priority over geopolitics, insisting avoiding World War III is the sole critical issue because presidents have sole discretion over foreign policy.
Biggest teaching moment ▶ 25:56 Chamath breaks down broken US IPO mechanicsChamath educates the room by systematically contrasting Asian and European IPO six-month lockup requirements with flawed American float concentration.
The host holds their own ▶ 46:59 Chamath demonstrates VC alpha decay using Axios dataChamath presents structured data evaluating private funding rounds against S&P 500 benchmarks to prove venture capital alpha disappears in high-rate environments.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | The hosts as informed peer | Guest teaching | Guest disagreement | The hosts pushing back | Why |
|---|---|---|---|---|---|---|
| Opening Banter: Cold Plunges and Pool Temperatures | 1 | 0 | 1 | 1 | Lighthearted banter among co-hosts regarding cold plunges, saunas, and pool temperatures. No real expertise or combativeness displayed. | |
| Hormone Replacement Therapy, HGH, and Celebrity Biohacking | 5 | 1 | 2 | 2 | Brief transition from hormone therapy to presidential politics where Chamath and Friedberg analyze Vivek Ramaswamy's polling surge and fiscal message. | |
| Geopolitics, Foreign Policy Priorities, and the National Debt | 7 | 2 | 3 | 5 | Sacks pushes back on Friedberg's question about fiscal crisis priority, arguing foreign policy and avoiding World War III is the primary presidential issue because foreign policy can be set unilaterally. | |
| All-In Summit 2023 Retrospective and Beverly Hills Hotel Banter | 2 | 0 | 1 | 2 | Co-hosts recap the All-In Summit, trade jokes about luxury hotel rooms, and recount banter regarding Summit organization. | |
| Summit Intellectual Highlights and Gwyneth Paltrow Clip | 3 | 1 | 1 | 1 | Review of top intellectual highlights from speakers at the summit and a audio clip played of guest Gwyneth Paltrow teasing David Sacks. | |
| Summit Production Behind-the-Scenes & Re-evaluating TED Conferences | 6 | 3 | 2 | 2 | Friedberg offers a structured critique of how TED conferences lost focus on technology and optimism, explaining why the All-In Summit was structured differently. | |
| Tech M&A Revival: Cisco Buys Splunk for $28 Billion | 8 | 2 | 3 | 3 | Chamath delivers a detailed breakdown contrasting European/Asian IPO allocation rules and six-month lockups with American bank-led float dynamics. | |
| State of the IPO Market & Post-IPO Value Accrual | 7 | 1 | 2 | 2 | Friedberg presents Ernst & Young data showing public market value creation and argues day-one IPO pop is a vanity metric. | |
| IPO Pricing Mechanics vs. Direct Listings | 8 | 3 | 3 | 4 | Chamath and Friedberg debate direct listings versus traditional IPOs, citing specific execution dynamics from Slack, Spotify, and Coinbase. | |
| Short-Term Market Price vs. Long-Term Fundamental Value | 7 | 1 | 2 | 3 | Friedberg shares a personal anecdote regarding Expedia stock in March 2009 to demonstrate how short-term market prices diverge from fundamental intrinsic value. | |
| Instacart Cap Table Data & VC Alpha in High-Rate Environments | 9 | 2 | 2 | 3 | Chamath presents Axios comparative chart data analyzing Instacart's series-by-series returns versus S&P 500 alpha in high interest rate regimes. | |
| Evolving LP Expectations & Venture Fund Strategy | 7 | 2 | 2 | 2 | Jason and Chamath detail changing LP expectations and the decay of take-rates in delivery platforms as suppliers gain pricing leverage. | |
| Klaviyo's IPO: SaaS Valuations & Shopify Platform Dependency | 8 | 2 | 3 | 3 | Sacks analyzes Klaviyo's financial metrics and highlights platform dependency risks given 70% of its revenue originates from Shopify. | |
| Airtable, Unbundling Excel, and AI Software Absorption | 7 | 2 | 2 | 3 | Sacks and Friedberg discuss how Airtable and spreadsheets capture long-tail enterprise workflows before specialized SaaS apps unbundle them. | |
| Unicorn Valuation Traps & Distressed Boardroom Recaps | 8 | 3 | 4 | 4 | Friedberg outlines how overvalued unicorns face painful boardroom recapitalizations and liquidation preference conflicts. | |
| Predatory Startup Recaps and Market End Game | 6 | 1 | 5 | 4 | Sacks forcefully labels distressed venture recaps as predatory transactions designed to squeeze out common holders and founders. | |
| Fed Policy, Inflation Lags, and Longer Startup Cash Runways | 8 | 2 | 3 | 3 | Chamath revises his previous economic forecast, instructing portfolio founders to extend cash runways through early 2026 due to hawkish Fed policy. | |
| Venture Capital Regime Change and Founder Realities | 7 | 2 | 2 | 2 | Sacks and Friedberg summarize the macroeconomic regime change from capital abundance to capital scarcity. | |
| Consumer Strain, Auto Union Strikes, and Automation Acceleration | 8 | 2 | 4 | 4 | Chamath explains how UAW strike demands pose an existential P&L threat to legacy automakers relative to non-unionized automated competitors like Tesla. | |
| Science Corner: Inverse Vaccines for Autoimmune Diseases | 9 | 1 | 2 | 2 | Friedberg explains groundbreaking Nature research on inverse vaccines using liver antigen presentation to reverse autoimmune diseases like MS. |